Skip to main content
Mark Applebaum, MD, Pediatric Hematology & Oncology, Chicago, IL, University of Chicago Medical Center

MarkApplebaumMD

Pediatric Hematology & Oncology Chicago, IL

Assistant Professor

Overview of Dr. Applebaum

Dr. Mark Applebaum is a pediatric hematologist/oncologist in Chicago, IL and is affiliated with multiple hospitals in the area, including University of Chicago Medical Center, Comer Childrens Hospital, Comer Childrens Hospital, and Comer Childrens Hospital. He received his medical degree from McGaw Medical Center of Northwestern University and has been in practice 9 years. He is one of 31 doctors at University of Chicago Medical Center and one of 28 doctors at Comer Childrens Hospital who specialize in Pediatric Hematology & Oncology. He has more than 50 publications and over 500 citings.

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Pediatric Hematology/Oncology, 2012 - 2015
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Pediatrics, 2008 - 2011
  • Northwestern University The Feinberg School of Medicine
    Northwestern University The Feinberg School of MedicineClass of 2008
  • University of California Division of Agriculture and Natural Resources
    University of California Division of Agriculture and Natural ResourcesB.A., Molecular and Cell Biology, 2000 - 2004

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2009 - Present
  • IL State Medical License
    IL State Medical License 2011 - 2026
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology
  • American Board of Clinical PharmacologyBoard Certification

Awards, Honors, & Recognition

  • Top 40 Under 40 Chicago Scientist Halo Cures, 2019
  • The James B. Nachman, MD Fellowship University of Chicago, 2018
  • Top Young Investigator Oral Abstract Advances in Neuroblastoma Research Congress, 2016
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Case Report Second Primary Rhabdomyosarcoma of the Uterine Cervix Presenting with Synchronous Ovarian Sertoli-Leydig Cell Tumor: An Illustrative Case of DICER1 Syndrome  
    Matthew Cowan, Melody Perpich, Mark A Applebaum, S Diane Yamada, Andrea D Olivas, Ricardo R Lastra, ScienceDirect
  • Evaluation of genetic predisposition for MYCN-amplified neuroblastoma  
    Hungate EA, Applebaum MA, Skol AD, Vaksman Z, Diamond M, McDaniel L, Volchenboum SL, Stranger BE, Diskin SJ, Maris JM, Onel K, Cohn SL, J Natl Cancer Inst, 1/1/2017

Books/Book Chapters

Abstracts/Posters

  • Second Malignancies in Patients with Neuroblastoma
    Applebaum MA, International Neuroblastoma Conference, Houston, TX, 1/1/2017
  • Whole Genome Analysis of the Epigenetic Mark 5-Hydroxymethylcysteine Reveals Differential Profiles in Low-, Intermediate-, and High-Risk Neuroblastoma
    Applebaum MA, AACR Conference on Pediatric Cancer Research, Atlanta, GA, 1/1/2017
  • Evaluation of Hypoxia Adaptation in Neuroblastoma Identifies Reproducible Transcriptional and Phenotypic Ressponses
    Applebaum MA, ASCPT Annual Meeting, San Diego, CA, 1/1/2016
  • Join now to see all

Other

Press Mentions

  • Potential for More Targeted Treatments of Neuroblastoma Tumors
    Potential for More Targeted Treatments of Neuroblastoma TumorsJune 19th, 2017
  • Texting Improves Link Between Sick Teens and Doctors
    Texting Improves Link Between Sick Teens and DoctorsMay 20th, 2014

Grant Support

  • Elucidating transcription regulation by epigenetics in neuroblastomaNCI2018–2022
  • Paul Calabresi Career Development in Clinical Oncology AwardNCI2016–2018
  • Young Investigator AwardCancer Research Foundation2016–2017
  • Young Investigator AwardConquer Cancer Foundation of ASCO2016–2017
  • Fellowship AwardBear Necessities Pediatric Cancer Foundation2015–2016
  • Training grant in Clinical Pharmacology and TherapeuticsNICHD2013–2016

Professional Memberships

Hospital Affiliations